accessibility menu, dialog, popup

UserName
Viewing profile as user:

Lipid Controls

Materials used to calibrate and monitor the performance of lipid tests.
Detectable Analytes 
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
Form 
  • (2)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (1)
  • (2)
  • (6)
  • (1)
  • (26)
  • (220)
  • (1)
  • (4)
  • (3)
  • (70)
  • (1)
  • (2)
  • (2)
  • (1)
  • (17)
  • (34)
  • (1)
  • (3)
  • (1)
  • (1)
  • (1)
  • (12)
  • (2)
  • (144)
  • (1)
  • (2)
  • (2)
  • (3)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (11)
  • (1)
  • (2)
  • (2)
  • (1)
  • (1)

special interests

  • (404)

Detectable Analytes

  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)

Form

  • (2)

Search Within Results
Keyword Search:
226 – 240 of 653 results
226

Avanti Polar Lipids 18:1 Lyso PG, 326495-24-3, MFCD00674367, powder, 500mg
SDP

Molecular Formula C24H46O9PNa, Purity >99% LPG; may contain up to 10% of the 2-LPG isomer, Formula Weight 532.580, Storage Temperature -20°C, 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)

ENCOMPASS
227

Medchemexpress LLC 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium salt | 474922-90-2 | MFCD02262251 | >99.0% | 2801.47 | C133H263N2O55P | 5 MG
SDP

18:1 PEG2000 PE ammonium salt is a PEGylated phosphoethanolamine that attaches a methoxy-PEG2000 chain to phosphatidylethanolamine, enabling incorporation of a hydrophilic PEG surface into lipid bilayers and nanoparticle formulations. It is used in liposome and nanoparticle preparation, membrane model studies, and surface modification to impart steric stabilization and reduce aggregation.

  • Provides steric stabilization to lipid bilayers and nanoparticles.
  • Increases hydrophilicity and reduces aggregation of lipid assemblies.
  • Suitable for liposome and nanoparticle formulation and membrane model systems.
  • Reported high purity (>99%), suitable for research applications.
  • Powder form; hygroscopic and recommended storage at -20 °C.

ENCOMPASS_PREFERRED
228

Sigma Aldrich Fine Chemicals Biosciences LIPOSOME KIT,(LIPID MIXT.5VLS)

Liposome Kit, 5vials of Lipd Mixture for the prep of Liposomes

ENCOMPASS
229

Avanti Polar Lipids 7-dehydrocholesterol | 434-16-2 | 5mg
SDP

7-dehydrocholesterol | Purity: 95% | Mol Wt: 384.644 | 434-16-2 | 5mg

ENCOMPASS
230

Medchemexpress LLC DLin-KC2-DMA | 1190197-97-7 | ≥98.0% | 642.09 | 25 MG
SDP

DLin-KC2-DMA is an ionizable cationic lipid (pKa≈6) that is virtually non-toxic to antigen presenting cells (APCs). It produces significant siRNA-mediated gene silencing of GAPDH when bound to lipid nanoparticles (LNP). DLin-KC2-DMA can be used in siRNA delivery studies.

  • Ionizable cationic lipid (pKa≈6).
  • Virtually non-toxic to antigen presenting cells (APCs).
  • Produces significant siRNA-mediated gene silencing of GAPDH when bound to lipid nanoparticles (LNP).
  • Can be used in siRNA delivery studies.
  • High uptake into macrophages and dendritic cells.
  • Efficiently promotes release of encapsulated siRNA into the cytosol following uptake via the endocytotic pathway.
  • Displays almost no toxicity in primary APCs.
  • Effective in silencing target genes in APCs in vivo (5 mg/kg; i.v.; single).

ENCOMPASS_PREFERRED
231

Cayman Chemical 1,3-Dioleoyl-2-Octanoyl Glycerol, Purity: ≥98%, CAS: 139979-77-4, 5 mg

A triacylglycerol; been used to characterize the functionality of R. oryzae lipase for regiodistribution analysis of fats containing medium- and short-chain fatty acids

ENCOMPASS_PREFERRED
232

eMolecules​ 1224606-06-7 | D-Lin-MC3-DMA | TargetMol642.110 | C43H79NO2 | 0.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 1mg | 812265962

D-Lin-MC3-DMA | TargetMol | 1224606-06-7642.110 | C43H79NO2 | 0.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 1mg | 812265962

ENCOMPASS_PREFERRED
233

eMolecules​ 1224606-06-7 | D-Lin-MC3-DMA | Target Molecule642.110 | C43H79NO2 | 0.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 10mg | 495883821

D-Lin-MC3-DMA | Target Molecule | 1224606-06-7642.110 | C43H79NO2 | 0.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 10mg | 495883821

ENCOMPASS_PREFERRED
234

Avanti Polar Lipids D-ERYTHRO-SPHINGOSINE-D7 5G
SDP

D-erythro-sphingosine-d7. 1246304-34-6

ENCOMPASS
235

eMolecules​ 62600-81-1 | 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049

1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | 62600-81-1 | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049

ENCOMPASS_PREFERRED
236

Avanti Polar Lipids 18 1 20 4 BMP R R 100MG
SDP

NC3873168 18 1 20 4 BMP R R 100MG

ENCOMPASS
237

Avanti Polar Lipids CARDIOLIPIN
SDP

1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (sodium salt). 115404-77-8

ENCOMPASS
238

Avanti Polar Lipids AVANTI POLAR LIPIDS INC
SDP

NC3908717 DSPE PEG2000-TCO 5MG

ENCOMPASS
239

Avanti Polar Lipids SPHINGOSINE 1 PHOSPHATE 1MG
SDP

D-erythro-sphingosine-1-phosphate. 26993-30-6

ENCOMPASS
240

Avanti Polar Lipids 1,2-DIHEPTANLYL-SN-GLYCERO/1GR
SDP

1,2-diheptanoyl-sn-glycero-3-phosphocholine. 39036-04-9

ENCOMPASS